This manuscript would benefit from further discussion on: The clinical relevance of the Lunasin concentration used in the mice studies. The rationale and the relevance of pretreating the cell lines with Lunasin prior to mouse engraftment. The pros/cons of this model compared with GEMM (including regulatory agency recommendations to better appraise the current drug development environment). 